ClinicalTrials.Veeva

Menu

Coffee Interaction With the Antihypertensive Drug Felodipine

L

Lawson Health Research Institute

Status and phase

Completed
Phase 1

Conditions

Food-Drug Interactions

Treatments

Other: Water
Other: Grapefruit Juice
Drug: Felodipine
Other: Black Coffee

Study type

Interventional

Funder types

Other

Identifiers

NCT02232269
R-11-655
NA-7122 (Other Grant/Funding Number)

Details and patient eligibility

About

Coffee is a globally popular beverage. More than half of the United States population spends an estimated $ 40 billion on the purchase of coffee each year. Personal consumption habits can vary. For example, the frequency of ingestion ranged from 59% for every day to 8% for less than one day per week consumption in one survey. In the case of occasional consumption, coffee can markedly elevate blood pressure in normotensive and hypertensive individuals. This pressor effect can occur with a caffeine dose of 200 - 250 mg, which can be found 2 - 3 cups of coffee. A major active constituent in coffee is caffeine, which is the most widely used pharmacological substance in the world.

Drug therapy plays a major role in the management of hypertension. However, the interaction between coffee or caffeine and blood pressure lowering drugs has been assessed in only three clinical studies that were reported more than three decades ago.

We conducted a comprehensive interaction study involving a commonly ingested amount of a particular Colombian coffee and felodipine in healthy middle-aged men and women. Peripheral (brachial) and central (aortic) hemodynamics and caffeine and felodipine pharmacokinetics were evaluated.

Enrollment

13 patients

Sex

All

Ages

30 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy (normal physical exam, blood clinical chemistry)
  • willingly signs ethics approved informed consent form

Exclusion criteria

  • history of cardiac, renal, hepatic or gastrointestinal disease or substance abuse
  • significant illness within 2 weeks of starting study
  • history of allergy to felodipine , tablet ingredients or dihydropyridines
  • routinely taking prescription or OTC drugs or natural health products
  • received an investigational drug withing the previous 4 weeks
  • females who are pregnant or breast-feeding

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

13 participants in 4 patient groups, including a placebo group

Water plus Felodipine
Placebo Comparator group
Description:
Felodipine extended-release tablet ,10 mg, single dose, 8 hours
Treatment:
Drug: Felodipine
Other: Water
Black Coffee
Active Comparator group
Description:
Black Coffee, 300 ml, 0 and 1 hour
Treatment:
Other: Black Coffee
Black Coffee plus Felodipine
Experimental group
Description:
Black Coffee, 300 ml, 0 and 1 hour Felodipine extended-release tablet ,10 mg, single dose, 8 hours
Treatment:
Other: Black Coffee
Drug: Felodipine
Grapefruit Juice plus Felodipine
Active Comparator group
Description:
Grapefruit Juice, 300 ml, 0 and 1 hour Felodipine extended-release tablet ,10 mg, single dose, 8 hours
Treatment:
Drug: Felodipine
Other: Grapefruit Juice

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems